Domača stranLLY • NYSE
add
Eli Lilly and Company
802,83 $
Po zaprtju:(0,090 %)−0,72
802,11 $
Konec trgovanja: 17. okt., 18:58:06 GMT -4 · USD · NYSE · Izjava
Prejšnji trg. dan.
819,38 $
Dnevni razpon
783,85 $ - 804,44 $
Letni razpon
623,78 $ - 935,63 $
Tržna kapitalizacija
759,84 mrd. USD
Povprečni obseg
3,61 mio.
Razm. P/E
52,44
Dividendna donosnost
0,75 %
Primarna borza
NYSE
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | jun. 2025info | Sprememba L/L |
|---|---|---|
Prihodek | 15,56 mrd. | 37,64 % |
Stroški poslovanja | 5,98 mrd. | 26,93 % |
Čisti dohodek | 5,66 mrd. | 90,78 % |
Čista dobičkovnost prihodkov | 36,38 | 38,59 % |
Earnings per share | 6,31 | 60,97 % |
EBITDA | 7,60 mrd. | 57,35 % |
Efektivna davčna stopnja | 16,47 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | jun. 2025info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 3,55 mrd. | 5,34 % |
Skupna sredstva | 100,92 mrd. | 40,41 % |
Skupne obveznosti | 82,57 mrd. | 41,78 % |
Celoten lastniški kapital | 18,35 mrd. | — |
Shares outstanding | 897,74 mio. | — |
Razmerje P/B | 40,22 | — |
Donosnost sredstev | 18,72 % | — |
Donosnost kapitala | 31,59 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | jun. 2025info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 5,66 mrd. | 90,78 % |
Denar iz dejavnosti | 3,09 mrd. | 110,54 % |
Denar iz naložb | −1,83 mrd. | 16,55 % |
Denar iz financiranja | −1,24 mrd. | −180,03 % |
Neto sprememba denarnih sredstev | 282,60 mio. | −62,98 % |
Prost denarni tok | 1,95 mrd. | −17,63 % |
Vizitka
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 11th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. Wikipedia
Generalni direktor
Datum ustanovitve
1876
Sedež organizacije
Spletno mesto
Zaposleni
47.000
